Galexxy Holdings Inc
Galexxy Holdings, Inc. operates as a health and wellness company. It engages in the provision of various functional mushroom products; and operation of a hemp store. The company was formerly known as AgTech Global International, Inc. and changed its name to Galexxy Holdings, Inc. in March 2022. Galexxy Holdings, Inc. was incorporated in 2000 and is based in Newport Beach, California. Galexxy Hold… Read more
Galexxy Holdings Inc (GXXY) - Net Assets
Latest net assets as of June 2025: $-698.28K USD
Based on the latest financial reports, Galexxy Holdings Inc (GXXY) has net assets worth $-698.28K USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($74.27K) and total liabilities ($772.55K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-698.28K |
| % of Total Assets | -940.21% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Galexxy Holdings Inc - Net Assets Trend (2019–2024)
This chart illustrates how Galexxy Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Galexxy Holdings Inc (2019–2024)
The table below shows the annual net assets of Galexxy Holdings Inc from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-696.38K | -32.84% |
| 2023-12-31 | $-524.24K | +42.88% |
| 2022-12-31 | $-917.82K | -120.66% |
| 2021-12-31 | $4.44 Million | +1287.81% |
| 2020-12-31 | $-374.08K | +65.71% |
| 2019-12-31 | $-1.09 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Galexxy Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2134508400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $284.31K | % |
| Other Components | $21.82 Million | % |
| Total Equity | $-813.55K | 100.00% |
Galexxy Holdings Inc Competitors by Market Cap
The table below lists competitors of Galexxy Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sequoia Econ Infrastructure
LSE:SEQI
|
$92.65 |
|
Figaro Coffee Group Inc
PSE:FCG
|
$92.65 |
|
Zenova Group PLC
LSE:ZED
|
$92.66 |
|
CNXXW
PINK:CNXXW
|
$92.69 |
|
MODERN BEAUTY SALON
MU:M3L
|
$92.44 |
|
AERWINS Technologies Inc.
OTCBB:AWIN
|
$92.43 |
|
Visual Healthcare Corp
PINK:MVNT
|
$92.35 |
|
LAMBOO RESOURCE
BE:F93
|
$92.22 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Galexxy Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -798,172 to -813,555, a change of -15,383.
- Net loss of 2,982,774 reduced equity.
- Other factors increased equity by 2,967,391.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.98 Million | -366.63% |
| Other Changes | $2.97 Million | +364.74% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Galexxy Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-0.02 | $0.01 | x |
| 2020-12-31 | $-0.01 | $0.01 | x |
| 2021-12-31 | $0.02 | $0.01 | x |
| 2022-12-31 | $0.00 | $0.01 | x |
| 2023-12-31 | $0.00 | $0.01 | x |
| 2024-12-31 | $0.00 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Galexxy Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2517.53%
- • Asset Turnover: 1.60x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-2.79%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -575.97% | 0.00x | 0.00x | $108.92K |
| 2020 | 0.00% | -806.17% | 0.33x | 0.00x | $-123.83K |
| 2021 | -16.72% | 0.00% | 0.00x | 1.14x | $-1.19 Million |
| 2022 | 0.00% | -3286.28% | 0.91x | 0.00x | $-17.52 Million |
| 2023 | 0.00% | -127.23% | 1.19x | 0.00x | $-1.26 Million |
| 2024 | 0.00% | -2517.53% | 1.60x | 0.00x | $-2.90 Million |
Industry Comparison
This section compares Galexxy Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Galexxy Holdings Inc (GXXY) | $-698.28K | 0.00% | N/A | $92.53 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |